The role of adiponectin in periodontitis: Current state and future prospects

Biomed Pharmacother. 2021 May:137:111358. doi: 10.1016/j.biopha.2021.111358. Epub 2021 Feb 6.

Abstract

Adiponectin (APN), which is an adipokine primarily secreted by adipose tissue into the peripheral blood, exerts anti-inflammatory and metabolic regulatory functions in many systemic inflammatory diseases. Periodontitis is a localized inflammatory disease and is also the sixth-leading complication of diabetes. Uncontrolled periodontal inflammation gradually destructs the periodontal supporting apparatus and leads to the consequent loss of teeth. Recently, emerging evidence has revealed an association between APN and periodontitis. Herein, we summarize the basic information of APN and its receptor agonists. We also overview current studies considering the role of APN in periodontitis and discuss the potential mechanisms in terms of inflammation and bone metabolism. At last, we outline the correlation between APN and systemic diseases related periodontitis. Above all, APN and its agonists are promising candidates for the treatment of periodontitis, while the underlying mechanisms and clinical translational application require further exploration.

Keywords: Adiponectin; Anti-inflammatory; Bone metabolism; Periodontitis.

Publication types

  • Review

MeSH terms

  • Adiponectin / agonists
  • Adiponectin / genetics
  • Adiponectin / metabolism*
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Bone and Bones / metabolism
  • Humans
  • Periodontitis / drug therapy
  • Periodontitis / genetics
  • Periodontitis / metabolism*
  • Receptors, Adiponectin / agonists
  • Receptors, Adiponectin / genetics
  • Receptors, Adiponectin / metabolism

Substances

  • Adiponectin
  • Anti-Inflammatory Agents
  • Receptors, Adiponectin